$$
CSL: Reaffirms FY 2023 Underlying Profit Guidance of US$2.7 Bln-US$2.8 Bln at Constant Currency
CSL: Interim Dividend US$1.07/Share
1H Total Revenue US$7.18 Bln, Up 19%
Guidance reaffirmed
$$
News: CSL UPDATE 1-CSL's half-year profit beats estimates on robust blood plasma collections, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$265.45 |
Change
1.495(0.57%) |
Mkt cap ! $128.4B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $265.51 | $259.33 | $103.4M | 393.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 37 | $265.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $265.46 | 34 | 2 |
View Market Depth
| Last trade - 13.52pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |